Spirometry with Reversibility at Dr. Essa Lab

Spirometry with Reversibility at Dr. Essa Lab

Spirometry with Reversibility at Dr. Essa Lab is a premier, non-invasive pulmonary function test (PFT) designed to assess lung function, measure airflow limitation, and evaluate the responsiveness of the airways to bronchodilator medications. Conducted at the state-of-the-art facilities of Dr. Essa Laboratory & Diagnostic Centre in Karachi, Pakistan, this diagnostic investigation is essential for patients experiencing respiratory symptoms such as chronic cough, wheezing, shortness of breath, and chest tightness. By measuring how much air you can inhale and exhale, and how quickly you can empty your lungs, spirometry serves as the gold standard for diagnosing obstructive airway diseases. The addition of a reversibility assessment—where measurements are taken before and after the administration of a fast-acting bronchodilator—allows clinical specialists to distinguish between different types of pulmonary conditions, most notably bronchial asthma and Chronic Obstructive Pulmonary Disease (COPD).

Understanding the mechanical and physiological aspects of your respiratory system is vital for effective treatment. During a Spirometry with Reversibility test at Dr. Essa Lab, advanced computerized spirometers capture precise physiological data, including the volume of air expired during the first second of a forced exhalation and the total volume of air exhaled. These objective metrics help pulmonologists, allergists, and general physicians formulate highly targeted, evidence-based treatment plans. Whether you require an initial diagnosis, pre-operative pulmonary clearance, or ongoing monitoring of a chronic lung condition, Dr. Essa Lab provides highly accurate, internationally standardized testing to support your respiratory health journey.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is critical to obtaining accurate and reproducible results during a Spirometry with Reversibility test. Patients are advised to adhere strictly to the following pre-test guidelines:

• Withhold Bronchodilators: Avoid using short-acting rescue inhalers (such as Salbutamol or Albuterol) for at least 4 to 6 hours prior to the test. Long-acting bronchodilators (such as Salmeterol, Formoterol, or Tiotropium) should be avoided for 12 to 24 hours, or as specifically directed by your referring physician.
• Avoid Smoking: Do not smoke cigarettes, use e-cigarettes, or expose yourself to secondhand smoke for at least 24 hours before the test, as tobacco smoke causes acute airway irritation and bronchoconstriction.
• Limit Caffeine and Alcohol: Avoid consuming coffee, tea, cola, energy drinks, or chocolate on the day of the test. Caffeine is a mild bronchodilator and can artificially alter the baseline test results. Avoid alcohol consumption for 24 hours prior to the procedure.
• Wear Comfortable Clothing: Wear loose-fitting clothes that do not restrict your chest or abdomen, allowing you to take deep, unrestricted breaths.
• Avoid Heavy Meals: Do not eat a large or heavy meal within 2 hours of your appointment. A full stomach can push upward against the diaphragm, preventing full lung expansion during the forced breathing maneuvers.
• Rest Before the Test: Arrive at Dr. Essa Lab at least 15 minutes before your scheduled test time to sit quietly and relax, ensuring your respiratory rate and heart rate are at baseline levels.

During the Procedure

The Spirometry with Reversibility procedure is safe, systematic, and completed in a controlled clinical environment under the close supervision of a trained pulmonary technician. The step-by-step process includes:

• Baseline Assessment: You will be seated comfortably in an upright position. A soft, comfortable clip will be placed on your nose to prevent air from escaping through your nostrils, ensuring all airflow passes solely through your mouth.
• Performing the Maneuver: You will be instructed to take a deep, maximal breath in, seal your lips tightly around the sterile, single-use mouthpiece of the spirometer, and blow the air out as hard, fast, and completely as possible. You must continue blowing until your lungs are completely empty, which typically takes at least 6 seconds.
• Ensuring Reproducibility: This forced expiratory maneuver is repeated at least three times to ensure the measurements are consistent, reliable, and meet international American Thoracic Society (ATS) and European Respiratory Society (ERS) quality standards.
• Bronchodilator Administration: Once a stable baseline is established, the technician will administer a standardized dose of a short-acting bronchodilator (typically 4 separate puffs of Salbutamol/Albuterol) using a sterile spacer device to ensure optimal delivery to the lower airways.
• The Waiting Period: You will rest quietly for approximately 10 to 15 minutes, allowing the medication to relax the smooth muscles surrounding your bronchial tubes.
• Post-Bronchodilator Testing: After the waiting period, you will repeat the forced expiratory maneuvers into the spirometer. The computer software will then compare your pre-bronchodilator (baseline) and post-bronchodilator results to calculate the percentage of improvement.

When is a Spirometry with Reversibility Performed?

Diagnosing Bronchial Asthma

Bronchial asthma is a chronic inflammatory disorder of the airways characterized by bronchial hyperresponsiveness and variable airflow obstruction. Physicians frequently request a Spirometry with Reversibility test at Dr. Essa Lab when a patient presents with classic asthma symptoms. A significant improvement in lung function after inhaling the bronchodilator confirms the presence of reversible airway obstruction, which is the hallmark physiological feature of asthma, allowing for an accurate and timely diagnosis.

Differentiating Asthma from Chronic Obstructive Pulmonary Disease (COPD)

Distinguishing between asthma and COPD can be clinically challenging because both conditions present with overlapping symptoms of dyspnea and wheezing. However, their underlying pathophysiology and treatment pathways differ significantly. While asthma features highly reversible airway obstruction, COPD is characterized by persistent, progressive, and largely irreversible airflow limitation. Spirometry with reversibility provides the objective physiological data required to differentiate these conditions, ensuring patients receive the correct therapeutic interventions.

Evaluating Unexplained Chronic Cough and Wheezing

A persistent, unexplained cough lasting more than eight weeks, or an audible wheezing sound during exhalation, warrants a comprehensive pulmonary evaluation. These symptoms can be early indicators of reactive airway disease, cough-variant asthma, or occupational lung disorders. Performing spirometry with reversibility helps clinicians identify subtle airway hyperreactivity that might not be apparent during a routine physical examination or on a standard chest X-ray.

Assessing Occupational Lung Disease and Environmental Exposure

Individuals exposed to industrial dust, chemical fumes, mold, or environmental pollutants in their workplace are at a high risk of developing occupational asthma or industrial bronchitis. Dr. Essa Lab conducts spirometry with reversibility to assess the impact of these environmental hazards on lung function. The test helps in early detection of occupational lung injuries, monitors disease progression, and provides essential documentation for occupational health clearances and disability claims.

Monitoring Therapeutic Response to Pulmonary Medications

For patients diagnosed with chronic respiratory diseases, regular monitoring is essential to ensure treatment efficacy. Physicians utilize spirometry with reversibility to evaluate how well a patient is responding to prescribed therapies, such as inhaled corticosteroids, long-acting bronchodilators, or biologic agents. Improved post-bronchodilator values over time indicate successful disease control, while declining values may prompt the clinician to adjust medication dosages or explore alternative therapies.

What Does a Spirometry with Reversibility Detect?

A Spirometry with Reversibility test at Dr. Essa Lab is highly sensitive and capable of detecting a wide range of physiological abnormalities, clinical patterns, and lung parameters, including:

• Normal baseline lung function with healthy lung volumes and flow rates.
• Significant bronchodilator reversibility, indicating highly reactive airways typical of asthma.
• Non-reversible airflow obstruction, highly suggestive of Chronic Obstructive Pulmonary Disease (COPD).
• Mild obstructive ventilatory defect, indicating early-stage airway narrowing.
• Moderate obstructive ventilatory defect, showing established airway resistance.
• Severe obstructive ventilatory defect, representing significant limitation in expiratory airflow.
• Very severe obstructive ventilatory defect, indicating critical airway obstruction.
• Restrictive lung pattern, characterized by a proportional reduction in all lung volumes (suggestive of interstitial lung disease, scoliosis, or neuromuscular weakness).
• Mixed obstructive-restrictive pattern, indicating coexisting airway narrowing and lung volume restriction.
• Reduced Forced Expiratory Volume in 1 Second (FEV1), reflecting the severity of airway obstruction.
• Reduced Forced Vital Capacity (FVC), indicating a reduction in the total volume of air exhaled.
• Decreased FEV1/FVC ratio, the primary diagnostic index used to confirm obstructive lung disease.
• Airway hyperreactivity, demonstrating acute sensitivity to environmental triggers.
• Fixed airway obstruction, showing no response to bronchodilators due to structural airway remodeling.
• Partial bronchodilator reversibility, often seen in overlapping asthma-COPD syndrome (ACOS).
• Small airway disease, indicated by isolated reductions in mid-expiratory flow rates (FEF 25-75%).
• Suboptimal patient effort, helping clinicians identify if poor performance was due to technical issues or physical limitations.
• Vocal cord dysfunction or upper airway obstruction, characterized by specific flattening of the inspiratory or expiratory flow-volume loops.
• Tracheobronchomalacia, indicated by characteristic expiratory flow patterns.
• Response to therapeutic interventions, confirming the physiological efficacy of current respiratory medications.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Laboratory & Diagnostic Centre is committed to providing rapid, accurate, and highly accessible diagnostic reporting. The raw data from your Spirometry with Reversibility test is generated immediately upon completion of the procedure. This data is then meticulously reviewed, interpreted, and signed off by a consultant pathologist or a qualified respiratory specialist to ensure clinical accuracy. Final verified reports are typically available within 24 to 48 hours. Patients can easily access their diagnostic reports online through the secure Dr. Essa Lab web portal, receive them directly via WhatsApp, or collect a high-quality printed copy from any of the convenient Dr. Essa Lab diagnostic branches across Karachi.

Spirometry with Reversibility Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Forced Expiratory Volume in 1 Second (FEV1)	≥ 80% of the predicted value based on age, sex, height, and ethnicity.	< 80% of the predicted value, indicating mild, moderate, or severe airway obstruction.
Forced Vital Capacity (FVC)	≥ 80% of the predicted value, demonstrating normal total lung capacity.	< 80% of the predicted value, suggesting restrictive lung disease or severe air trapping.
FEV1/FVC Ratio	≥ 0.70 (or above the Lower Limit of Normal, depending on age).	< 0.70, confirming the clinical presence of obstructive airway disease (e.g., Asthma, COPD).
Bronchodilator Reversibility	An increase in FEV1 or FVC of < 12% and < 200 mL after bronchodilator inhalation.	An increase in FEV1 or FVC of ≥ 12% and ≥ 200 mL, confirming significant reversibility (Asthma).
Peak Expiratory Flow (PEF)	Within normal limits for demographic parameters, indicating strong initial expiratory force.	Significantly reduced, indicating large airway obstruction, muscle weakness, or poor patient effort.
Forced Expiratory Flow (FEF 25-75%)	≥ 60% of the predicted value, indicating healthy small and mid-sized airways.	< 60% of the predicted value, indicating early small airway disease or localized inflammation.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Spirometry with Reversibility?

• Experienced Healthcare Professionals: Our pulmonary function tests are conducted by highly trained, certified technicians specializing in respiratory diagnostics.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the entire testing process.
• Quality Diagnostic Services: Dr. Essa Lab adheres to strict international quality control protocols to ensure highly reproducible and accurate results.
• Professional Reporting: Every spirometry report is thoroughly reviewed and interpreted by experienced consultant specialists.
• Modern Diagnostic Approach: We utilize state-of-the-art, computerized spirometers equipped with advanced software for precise measurements.
• Comfortable Environment: Our diagnostic centers offer clean, hygienic, and welcoming testing environments designed for patient ease.
• Convenient Location: With an extensive network of branches across Karachi, accessing quality diagnostic care is always convenient.
• Commitment to Accurate Diagnosis: Established in 1987, Dr. Essa Lab is a trusted household name in Pakistan, recognized for diagnostic excellence and integrity.